DF

Dominik Feuerbach

NA Novartis Ag: 23 patents #44 of 5,128Top 1%
Overall (All Time): #177,011 of 4,157,543Top 5%
23
Patents All Time

Issued Patents All Time

Showing 1–23 of 23 patents

Patent #TitleCo-InventorsDate
12215387 Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment Baltazar Gomez-Mancilla, Yunsheng He, Donald Johns, Cristina Lopez-Lopez, Kevin Hall McAllister +3 more 2025-02-04
11492402 TREM2 stabilizing antibodies Verena BRAND, Fabrizio Gasparini, Nathalie George, Eveline Schaadt, Derya SHIMSHEK +3 more 2022-11-08
11359241 Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment Baltazar Gomez-Mancilla, Yunsheng He, Donald Johns, Cristina Lopez-Lopez, Kevin Hall McAllister +3 more 2022-06-14
11311525 Use of alpha 7 nicotinic acetylcholine receptor agonists Markus FENDT, Sjoerd Johannes Finnema, Christer Halldin, Donald Johns, Cristina Lopez-Lopez +3 more 2022-04-26
11096916 Use of nicotinic acetylcholine receptor alpha 7 activators Therese Di Paolo, Baltazar Gomez-Mancilla, Donald Johns 2021-08-24
10537539 Use of nicotinic acetylcholine receptor alpha 7 activators Therese Di Paolo, Baltazar Gomez-Mancilla, Donald Johns 2020-01-21
9849117 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists Konstanze Hurth, Timothy John Ritchie, Rochdi Bouhelal 2017-12-26
9828642 Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment Baltazar Gomez-Mancilla, Yunsheng He, Donald Johns, Cristina Lopez-Lopez, Kevin Hall McAllister +3 more 2017-11-28
9657010 Substituted quinuclidines as alpha 7-nicotinic acetylcholine receptor activity modulators Mathias Frederiksen, Konstanze Hurth, Bernard Lucien Roy 2017-05-23
9567343 Aza-bicyloalkyl ethers and their use as alpha7-nachr agonists Konstanze Hurth, Timothy John Ritchie, Rochdi Bouhelal 2017-02-14
9475811 1-aza-bicyclo[3.3.1]nonanes Werner Müller, Bernard Lucien Roy, Thomas J. Troxler, Konstanze Hurth, Mathias Frederiksen 2016-10-25
9206181 1-aza-bicyclo[3.3.1] non-4-yl)-[5-(1H-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenerative disorders Mathias Frederiksen, Konstanze Hurth, Manuel Koller, Bernard Lucien Roy 2015-12-08
9012451 Aza-bicycloalkyl ethers and their use as ALPHA7-nachr agonists Konstanze Hurth, Timothy John Ritchie 2015-04-21
8933090 1-aza-bicyclo[3.3.1]nonanes Werner Müller, Bernard Lucien Roy, Thomas J. Troxler, Konstanze Hurth, Mathias Frederiksen 2015-01-13
8759346 Organic compounds Mathias Frederiksen, Konstanze Hurth, Manuel Koller, Bernard Lucien Roy 2014-06-24
8637517 Organic compounds Mathias Frederiksen, Konstanze Hurth, Bernard Lucien Roy, Beatrix Wagner 2014-01-28
8609662 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha. 7-nachr ligands for the treatment of CNS diseases Mathias Frederiksen, Konstanze Hurth, Bernard Lucien Roy 2013-12-17
8236803 Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonists Konstanze Hurth, Timothy John Ritchie 2012-08-07
8173667 1-aza-bicycloalkyl derivatives Mathias Frederiksen, Martin Marzi, Bernard Lucien Roy 2012-05-08
8048885 Organic compounds Mathias Frederiksen, Konstanze Hurth, Bernard Lucien Roy, Beatrix Wagner 2011-11-01
7713976 [(1H-indol-5-yl)-heteroaryloxy]-1-aza-bicylco[3.3.1]nonanes as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenerative disorders Mathias Frederiksen, Konstanze Hurth, Bernard Lucien Roy, Beatrix Wagner 2010-05-11
7713977 (1-aza-bicyclo[3.3.1]non-4-yl)-[5-(1H-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenerative disorders Mathias Frederiksen, Konstanze Hurth, Bernard Lucien Roy, Manuel Koller 2010-05-11
7579362 Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonists Konstanze Hurth, Timothy John Ritchie 2009-08-25